Secukinumab is effective in the treatment of recalcitrant palmoplantar psoriasis and palmoplantar pustular psoriasis in a daily practice setting

Por: Reolid, A, Armesto, S, Sahuquillo-Torralba, A, Torres, T, Feltes, R, Vilarrasa, E, Belincho, I, de la Cueva, P, Rodriguez, L, Romero-Mate, A, Vidal, D, Coto-Segura, P, Herrera-Acosta, E, Riera-Monroig, J, Salgado, L, Llamas-Velasco, M, Dauden, E

---

Publicada: 1 sep 2022 Ahead of Print: 1 ago 2022

---

---

Filiaciones:
Reolid, A:
 Hosp Univ la Princesa, Diego Leon 62, Madrid 28006, Spain

Armesto, S:
 Hosp Univ Marques Valdecilla, Santander, Spain

Sahuquillo-Torralba, A:
 Hosp Univ & Politecn La Fe, Inst Invest Sanitaria la Fe, Valencia, Spain

Torres, T:
 Ctr Hosp Univ Porto, Porto, Portugal

Feltes, R:
 Hosp Univ La Paz, Madrid, Spain

Vilarrasa, E:
 Hosp Santa Creu St Pau, Barcelona, Spain

Belincho, I:
 Hosp Gen Univ Alicante, Invest Sanitaria & Biomed Alicante, Alicante, Spain

de la Cueva, P:
 Hosp Univ Infanta Leonor, Madrid, Spain

Rodriguez, L:
 Hosp Univ Virgen Rocio, Seville, Spain

Romero-Mate, A:
 Hosp Fuenlabrada, Madrid, Spain

Vidal, D:
 Hosp St Joan Despi Moises Broggi, Barcelona, Spain

Coto-Segura, P:
 Hosp Vital varez Buylla Mieres, Asturias, Spain

Herrera-Acosta, E:
 Hosp Virgen Victoria, Malaga, Spain

Riera-Monroig, J:
 Hosp Clin Barcelona, Barcelona, Spain

Salgado, L:
 Complejo Hosp Univ, Pontevedra, Spain

Llamas-Velasco, M:
 Hosp Univ la Princesa, Diego Leon 62, Madrid 28006, Spain

Dauden, E:
 Hosp Univ la Princesa, Diego Leon 62, Madrid 28006, Spain